Canada Sepsis Diagnostics Market Size & Outlook, 2026-2033
- Clinical Diagnostics
- In Vitro Diagnostics
- Sepsis Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI about the sepsis diagnostics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Canada sepsis diagnostics market highlights
- The Canada sepsis diagnostics market generated a revenue of USD 46.5 million in 2025 and is expected to reach USD 91.6 million by 2033.
- The Canada market is expected to grow at a CAGR of 9% from 2026 to 2033.
- In terms of segment, conventional diagnostics was the largest revenue generating method in 2025.
- Automated Diagnostics is the most lucrative method segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2025 | USD 46.5 million |
| Market revenue in 2033 | USD 91.6 million |
| Growth rate | 9% (CAGR from 2026 to 2033) |
| Largest segment | Conventional diagnostics |
| Fastest growing segment | Automated Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Automated Diagnostics, Conventional Diagnostics |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Canada accounted for 3.8% of the global sepsis diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 55.9 million by 2033.
The sepsis diagnostics market in Canada is witnessing robust growth, propelled by a combination of demographic trends, technological advancements, and healthcare policy initiatives.
According to Canadian Sepsis Foundation, 1 in 18 deaths is associated with sepsis, making it the 12th largest cause of death. The rate of Hospital-Acquired Infections (HAIs) in Canada is also increasing. This indicated that in 2022–2023, approximately 1 in every 17 hospitalized patients experienced unintended harm during their hospital stay.
Canadian healthcare authorities have been proactive in implementing guidelines and protocols for the early detection & management of sepsis. The Public Health Agency of Canada (PHAC) and other regulatory bodies are increasingly focusing on improving sepsis outcomes through awareness campaigns and education programs aimed at both healthcare professionals and the general public.
No credit card required*
Publish Date: Jun 10, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Luminex | View profile | 501-1000 | Austin, Texas, United States, North America | www.luminexcorp.com |
| Cepheid | View profile | 1001-5000 | Sunnyvale, California, United States, North America | www.cepheid.com |
| Immunexpress | View profile | 11-50 | Seattle, Washington, United States, North America | www.immunexpress.com |
Canada Sepsis Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Sepsis Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Conventional Diagnostics was the largest segment with a revenue share of 62.58% in 2025.
Horizon Databook has segmented the Canada sepsis diagnostics market based on automated diagnostics, conventional diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.
The sepsis diagnostics market in Canada is witnessing robust growth, propelled by a combination of demographic trends, technological advancements, and healthcare policy initiatives.
According to Canadian Sepsis Foundation, 1 in 18 deaths is associated with sepsis, making it the 12th largest cause of death. The rate of Hospital-Acquired Infections (HAIs) in Canada is also increasing. This indicated that in 2022–2023, approximately 1 in every 17 hospitalized patients experienced unintended harm during their hospital stay.
Canadian healthcare authorities have been proactive in implementing guidelines and protocols for the early detection & management of sepsis. The Public Health Agency of Canada (PHAC) and other regulatory bodies are increasingly focusing on improving sepsis outcomes through awareness campaigns and education programs aimed at both healthcare professionals and the general public.
- Canada Sepsis Diagnostics Market Method Outlook (Revenue, USD Million , 2021-2033)
- Automated Diagnostics
- Conventional Diagnostics
- Canada Sepsis Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Immunoassays
- Others
- Microbiology
- Flow Cytometry
- Molecular Diagnostics
- Canada Sepsis Diagnostics Market Pathogen Outlook (Revenue, USD Million , 2021-2033)
- Bacterial Sepsis
- Fungal Sepsis
- Viral Sepsis and Others
- Canada Sepsis Diagnostics Market Testing Type Outlook (Revenue, USD Million , 2021-2033)
- Laboratory Testing
- Point-of-Care Testing
- Canada Sepsis Diagnostics Market End User Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & Clinics
- Pathology & Reference Laboratories
- Research Institutes and Others
- Canada Sepsis Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Blood Culture Media
- Assay Kits & Reagents
- Software
Reasons to subscribe to Sepsis Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sepsis Diagnostics Market Outlook databook
- Our clientele includes a mix of Sepsis Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Sepsis Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada Sepsis Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Canada Sepsis Diagnostics Market, 2021-2033 (US$M)
Canada sepsis diagnostics market statistics, by method, 2021-2033 (US$M)
